Symbols / ACHV

ACHV Chart
About

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 237.96M
Enterprise Value 195.54M Income -52.35M Sales —
Book/sh 0.64 Cash/sh 0.90 Dividend Yield —
Payout 0.00% Employees 25 IPO —
P/E — Forward P/E -3.78 PEG —
P/S — P/B 7.03 P/C —
EV/EBITDA -3.75 EV/Sales — Quick Ratio 4.95
Current Ratio 5.14 Debt/Eq 29.62 LT Debt/Eq —
EPS (ttm) -1.35 EPS next Y -1.18 EPS Growth —
Revenue Growth — Earnings 2026-03-10 ROA -65.45%
ROE -161.08% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 53.23M
Shs Float 47.12M Short Float 14.96% Short Ratio 7.50
Short Interest — 52W High 6.03 52W Low 1.84
Beta 1.84 Avg Volume 651.46K Volume 84.27K
Target Price $15.38 Recom None Prev Close $4.39
Price $4.47 Change 1.82%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.38
Mean price target
2. Current target
$4.39
Latest analyst target
3. DCF / Fair value
$-7.36
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.39
Low
$10.00
High
$25.00
Mean
$15.38

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-25 init Citizens — → Market Outperform $19
2025-08-21 init HC Wainwright & Co. — → Buy $12
2024-11-14 init Rodman & Renshaw — → Buy $12
2024-08-15 reit Oppenheimer Outperform → Outperform $11
2024-05-13 main Oppenheimer Outperform → Outperform $11
2024-04-17 init JonesTrading — → Buy $20
2024-04-01 reit Oppenheimer Outperform → Outperform $18
2024-03-05 main Lake Street Buy → Buy $11
2023-12-12 main Oppenheimer Outperform → Outperform $18
2023-05-31 main Lake Street Buy → Buy $19
2023-05-10 main Lake Street Buy → Buy $22
2023-03-17 reit Oppenheimer — → Outperform $17
2022-11-16 main Maxim Group — → Buy $8
2021-10-04 init Alliance Global Partners — → Buy $25
2021-06-23 init Oppenheimer — → Outperform $23
2020-09-17 init Lake Street — → Buy $30
2020-02-25 init HC Wainwright & Co. — → Buy $2
2019-06-14 init Maxim Group — → Buy $6
News
RSS: Latest ACHV news
Insider Transactions
Date Shares Url Text Insider Position Transaction Start Date Ownership Value
0 69 — — JACOBS CINDY A Officer — 2020-08-18 00:00:00 D nan
1 69 — — BENCICH JOHN A Chief Operating Officer — 2020-08-18 00:00:00 D nan
2 1370 — — BENCICH JOHN A Chief Operating Officer — 2019-08-13 00:00:00 D nan
3 264963 — Sale at price 2.53 - 3.38 per share. ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security — 2019-06-11 00:00:00 I 755856.0
4 47182 — Sale at price 2.85 - 3.01 per share. ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security — 2019-06-11 00:00:00 I 134821.0
5 42 — — JACOBS CINDY A Officer — 2019-01-15 00:00:00 D nan
6 28 — — BENCICH JOHN A Chief Operating Officer — 2019-01-15 00:00:00 D nan
Financials
Line Item2024-12-312023-12-312022-12-312021-12-31
TaxEffectOfUnusualItems0.000.000.000.00
TaxRateForCalcs0.000.000.000.00
NormalizedEBITDA-36.51M-26.21M-40.33M-32.90M
TotalUnusualItems-904.00K-528.00K0.000.00
TotalUnusualItemsExcludingGoodwill-904.00K-528.00K0.000.00
NetIncomeFromContinuingOperationNetMinorityInterest-39.83M-29.82M-42.35M-33.15M
ReconciledDepreciation229.00K228.00K236.00K250.00K
EBITDA-37.42M-26.73M-40.33M-32.90M
EBIT-37.65M-26.96M-40.56M-33.15M
NetInterestIncome176.00K-2.03M-1.59M17.00K
InterestExpense2.18M2.85M1.79M0.00
InterestIncome2.36M825.00K199.00K17.00K
NormalizedIncome-38.92M-29.29M-42.35M-33.15M
NetIncomeFromContinuingAndDiscontinuedOperation-39.83M-29.82M-42.35M-33.15M
TotalExpenses39.07M27.25M40.80M33.09M
DilutedAverageShares32.07M19.83M10.59M8.12M
BasicAverageShares32.07M19.83M10.59M8.12M
DilutedEPS-1.24-1.50-4.00-4.08
BasicEPS-1.24-1.50-4.00-4.08
DilutedNIAvailtoComStockholders-39.83M-29.82M-42.35M-33.15M
NetIncomeCommonStockholders-39.83M-29.82M-42.35M-33.15M
NetIncome-39.83M-29.82M-42.35M-33.15M
NetIncomeIncludingNoncontrollingInterests-39.83M-29.82M-42.35M-33.15M
NetIncomeContinuousOperations-39.83M-29.82M-42.35M-33.15M
PretaxIncome-39.83M-29.82M-42.35M-33.15M
OtherIncomeExpense-934.00K-537.00K40.00K-75.00K
OtherNonOperatingIncomeExpenses-30.00K-9.00K40.00K-75.00K
SpecialIncomeCharges-904.00K-528.00K0.000.00
OtherSpecialCharges283.00K
RestructuringAndMergernAcquisition621.00K528.00K0.000.00
NetNonOperatingInterestIncomeExpense176.00K-2.03M-1.59M17.00K
InterestExpenseNonOperating2.18M2.85M1.79M0.00
InterestIncomeNonOperating2.36M825.00K199.00K17.00K
OperatingIncome-39.07M-27.25M-40.80M-33.09M
OperatingExpense39.07M27.25M40.80M33.09M
ResearchAndDevelopment22.82M15.81M30.08M23.97M
SellingGeneralAndAdministration16.25M11.44M10.72M9.13M
GeneralAndAdministrativeExpense16.25M11.44M10.72M9.13M
OtherGandA16.25M11.44M10.72M9.13M
TotalRevenue0.000.000.000.00
OperatingRevenue0.000.000.000.00
Line Item2024-12-312023-12-312022-12-312021-12-31
OrdinarySharesNumber34.69M21.17M17.90M9.45M
ShareIssued34.69M21.17M17.90M9.45M
NetDebt1.17M
TotalDebt9.96M16.73M16.20M14.99M
TangibleBookValue18.89M-3.68M5.85M25.37M
InvestedCapital30.74M15.21M24.37M42.96M
WorkingCapital29.79M-3.83M5.73M40.04M
NetTangibleAssets18.89M-3.68M5.85M25.37M
CapitalLeaseObligations121.00K69.00K127.00K73.00K
CommonStockEquity20.90M-1.45M8.30M28.04M
TotalCapitalization30.74M-1.45M8.30M42.96M
TotalEquityGrossMinorityInterest20.90M-1.45M8.30M28.04M
StockholdersEquity20.90M-1.45M8.30M28.04M
GainsLossesNotAffectingRetainedEarnings31.00K4.00K4.00K4.00K
OtherEquityAdjustments31.00K4.00K4.00K4.00K
RetainedEarnings-205.58M-165.75M-135.94M-93.59M
AdditionalPaidInCapital226.34M164.21M144.15M121.55M
CapitalStock103.00K90.00K87.00K79.00K
CommonStock103.00K90.00K87.00K79.00K
PreferredStock0.000.000.000.00
TotalLiabilitiesNetMinorityInterest17.73M20.82M21.67M19.47M
TotalNonCurrentLiabilitiesNetMinorityInterest11.05M6.00K69.00K14.92M
OtherNonCurrentLiabilities1.15M
LongTermDebtAndCapitalLeaseObligation9.90M6.00K69.00K14.92M
LongTermCapitalLeaseObligation66.00K6.00K69.00K4.00K
LongTermDebt9.84M14.92M
CurrentLiabilities6.68M20.81M21.60M4.55M
OtherCurrentLiabilities528.00K
CurrentDebtAndCapitalLeaseObligation55.00K16.73M16.13M69.00K
CurrentCapitalLeaseObligation55.00K63.00K58.00K69.00K
CurrentDebt16.66M16.07M
OtherCurrentBorrowings16.66M16.07M
PensionandOtherPostRetirementBenefitPlansCurrent3.03M2.31M1.68M1.94M
PayablesAndAccruedExpenses3.60M1.25M3.79M2.54M
CurrentAccruedExpenses1.65M631.00K2.13M1.70M
Payables1.95M618.00K1.66M841.00K
AccountsPayable1.95M618.00K1.66M841.00K
TotalAssets38.63M19.37M29.97M47.52M
TotalNonCurrentAssets2.17M2.39M2.64M2.92M
OtherNonCurrentAssets39.00K92.00K66.00K183.00K
GoodwillAndOtherIntangibleAssets2.01M2.23M2.45M2.67M
OtherIntangibleAssets974.00K1.20M1.42M1.64M
Goodwill1.03M1.03M1.03M1.03M
NetPPE119.00K66.00K123.00K64.00K
AccumulatedDepreciation-299.00K-287.00K
GrossPPE119.00K66.00K123.00K64.00K
Leases25.00K26.00K
OtherProperties119.00K66.00K123.00K64.00K
MachineryFurnitureEquipment259.00K257.00K
Properties0.000.00
CurrentAssets36.47M16.98M27.33M44.59M
OtherCurrentAssets2.11M1.32M2.45M1.42M
RestrictedCash20.00K50.00K50.00K
PrepaidAssets1.42M
Receivables0.00111.00K105.00K153.00K
OtherReceivables111.00K105.00K153.00K
CashCashEquivalentsAndShortTermInvestments34.34M15.50M24.72M43.02M
OtherShortTermInvestments21.61M0.00
CashAndCashEquivalents12.73M15.50M24.72M43.02M
CashEquivalents12.13M14.25M22.76M41.86M
CashFinancial598.00K1.24M1.97M1.16M
Line Item2024-12-312023-12-312022-12-312021-12-31
FreeCashFlow-29.77M-24.50M-37.57M-29.44M
RepurchaseOfCapitalStock0.00-30.00K
RepaymentOfDebt-18.11M0.000.00
IssuanceOfDebt9.81M0.000.0014.93M
IssuanceOfCapitalStock56.08M15.30M19.21M21.34M
CapitalExpenditure-21.00K
EndCashPosition12.77M15.60M24.82M43.07M
BeginningCashPosition15.60M24.82M43.07M35.90M
EffectOfExchangeRateChanges0.00-3.00K3.00K-1.00K
ChangesInCash-2.82M-9.22M-18.25M7.17M
FinancingCashFlow48.53M15.28M19.32M36.61M
CashFlowFromContinuingFinancingActivities48.53M15.28M19.32M36.61M
NetOtherFinancingCharges-114.00K-220.00K-47.00K
ProceedsFromStockOptionExercised860.00K227.00K150.00K338.00K
NetCommonStockIssuance56.08M15.27M19.21M21.34M
CommonStockPayments0.00-30.00K
CommonStockIssuance56.08M15.30M19.21M21.34M
NetIssuancePaymentsOfDebt-8.29M0.000.0014.93M
NetLongTermDebtIssuance-8.29M0.000.0014.93M
LongTermDebtPayments-18.11M0.000.00
LongTermDebtIssuance9.81M0.000.0014.93M
InvestingCashFlow-21.58M-21.00K0.000.00
CashFlowFromContinuingInvestingActivities-21.58M-21.00K0.000.00
NetInvestmentPurchaseAndSale-21.58M0.000.000.00
SaleOfInvestment26.31M0.000.000.00
PurchaseOfInvestment-47.89M0.000.000.00
NetPPEPurchaseAndSale0.00-21.00K0.000.00
PurchaseOfPPE0.00-21.00K0.000.00
OperatingCashFlow-29.77M-24.48M-37.57M-29.44M
CashFlowFromContinuingOperatingActivities-29.77M-24.48M-37.57M-29.44M
ChangeInWorkingCapital2.41M-778.00K79.00K1.23M
ChangeInOtherWorkingCapital-263.00K466.00K
ChangeInOtherCurrentLiabilities-1.00K-58.00K-5.00K-14.00K
ChangeInPayablesAndAccruedExpense3.07M-1.89M967.00K1.63M
ChangeInAccruedExpense1.74M-848.00K168.00K1.12M
ChangeInPayable1.33M-1.04M799.00K509.00K
ChangeInAccountPayable1.33M-1.04M799.00K509.00K
ChangeInPrepaidAssets-765.00K1.18M-931.00K-228.00K
ChangeInReceivables111.00K-6.00K48.00K-153.00K
OtherNonCashItems1.81M2.45M1.20M41.00K
StockBasedCompensation5.33M3.44M3.27M2.19M
DepreciationAmortizationDepletion229.00K228.00K236.00K250.00K
DepreciationAndAmortization229.00K228.00K236.00K250.00K
AmortizationCashFlow223.00K
AmortizationOfIntangibles223.00K
Depreciation27.00K
OperatingGainsLosses283.00K
NetIncomeFromContinuingOperations-39.83M-29.82M-42.35M-33.15M
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Public Trades for ACHV
Date User Asset Broker Type Position Size Entry Price Patterns